DRI Healthcare Trust (TSE:DHT.UN) Price Target Raised to C$26.00 at Stifel Nicolaus

DRI Healthcare Trust (TSE:DHT.UN) had its target price boosted by equities research analysts at Stifel Nicolaus from C$25.00 to C$26.00 in a research report issued to clients and investors on Tuesday,BayStreet.CA reports. The brokerage presently has a “buy” rating on the stock. Stifel Nicolaus’ price objective indicates a potential upside of 36.13% from the stock’s previous close.

DHT.UN has been the subject of several other research reports. Raymond James Financial increased their target price on shares of DRI Healthcare Trust from C$22.50 to C$23.50 and gave the company a “strong-buy” rating in a research note on Monday, June 29th. Canaccord Genuity Group boosted their price target on DRI Healthcare Trust from C$22.25 to C$23.00 and gave the company a “buy” rating in a research note on Tuesday, June 30th. National Bank Financial upped their price target on DRI Healthcare Trust from C$22.50 to C$23.50 and gave the company an “outperform” rating in a report on Tuesday, May 19th. Finally, Scotiabank raised their price objective on DRI Healthcare Trust from C$25.00 to C$30.00 and gave the stock a “sector outperform” rating in a research report on Tuesday, May 19th. One research analyst has rated the stock with a Strong Buy rating and four have given a Buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus target price of C$25.20.

DRI Healthcare Trust Stock Up 6.1%

DRI Healthcare Trust stock traded up C$1.09 during mid-day trading on Tuesday, reaching C$19.10. The company had a trading volume of 94,322 shares, compared to its average volume of 58,234. The firm has a market cap of C$1.05 billion, a price-to-earnings ratio of -21.22 and a beta of 0.35. The company has a 50 day moving average of C$18.09 and a 200-day moving average of C$17.05. DRI Healthcare Trust has a 52 week low of C$13.90 and a 52 week high of C$19.75.

DRI Healthcare Trust Company Profile

DRI Healthcare Trust is managed by DRI Capital Inc DRI a pioneer in global pharmaceutical royalty monetization. We provide uniquely favorable exposure for investors in the biopharma industry managing a diversified portfolio of interests in medicines that have a demonstrable positive impact on the world and aiming to acquire dependable patent-protected cash flow streams derived from the sales of those important drugs while limiting the risks and costs connected to drug development. DRI has developed a disciplined strategy predicated on actively sourcing royalty streams on medically necessary products and proudly work with multiple repeat deal partners.DRI Healthcare Trust is an unincorporated open-ended trust governed by the laws of the Province of Ontario pursuant to a declaration of trust dated October 21 2020 as amended.DRI Healthcare Trusts units are listed and trade on the Toronto Stock Exchange under DHT.UN in Canadian dollars and under DHT.U in U.S.